Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma

doi:10.3748/wjg.v25.i34.5049

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 34

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9036)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

521

WORD

208

HTML

3640

Figures (1-1)

138

Tables (1-5)

213

Sum=4720

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

844

Download

1580

Sum=2424

Publishing Process of This Article

Item

Count

Browse

739

Download

1153

Sum=1892

Sep 14, 2019 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Sep 14, 2019; 25(34): 5049-5068
Published online Sep 14, 2019. doi: 10.3748/wjg.v25.i34.5049

Open in New Tab Full Size Figure Download Figure

Figure 1 Graphical representation of sensitivity versus specificity for single tumor-associated autoantibody biomarkers in esophageal squamous cell carcinoma reported in more than one study. Mmp-7: Matrix metallopeptidase 7; Hsp70: Heat shock protein 70; PRDX 6: Peroxiredoxin 6; Bmi-1: BMI1 proto-oncogene, polycomb ring finger; Koc: Insulin-like growth factor 2 mRNA binding protein 3; C-Myc: MYC proto-oncogene, bHLH transcription factor; IMP1: Insulin-like growth factor 2 mRNA binding protein 1.

Citation: Xu YW, Peng YH, Xu LY, Xie JJ, Li EM. Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma. World J Gastroenterol 2019; 25(34): 5049-5068
URL: https://www.wjgnet.com/1007-9327/full/v25/i34/5049.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i34.5049